This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
E23.1#
1 out of 7 registries used, show all original rules.
28
Check minimum number of events None
28
Include endpoints None
28
Remove individuals based on genotype QC
27
DRUGADVERS_HYPOPI
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF5
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Drug-induced hypopituitarism
based on the number of shared cases.
Broader endpoints:
- Hypothalamic dysfunction, including iatrogenic, not elsewhere classified
- Exclusions for E4_PCOS_BROAD
- Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT
- Disorders of other endocrine glands
- Exclusions for E4_PCOS_CONSORTIUM
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 27 | 11 | 16 |
| Unadjusted prevalence (%) | 0.01 | 0.00 | 0.01 |
| Mean age at first event (years) | 31.22 | 25.94 | 34.85 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: DRUGADVERS_HYPOPI – Drug-induced hypopituitarism
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Drug-induced hypopituitarism
↥Endpoint not on priority list, no data to show.